Rita Jacob

Rita Jacob, a proven Clinical Affairs strategist, joined MMS in 2022. She brings a history of collaborating with medical device company executives and key stakeholders to deliver results in FDA regulated clinical research, medical training and scientific marketing. After spending nearly a decade in cardiovascular intensive care nursing, Rita evolved her passion for exceptional patient care to delivering novel high-risk medical devices into physicians’ hands for over 25 years. Her career has included Fortune 100 and 500 companies as well as many start-up companies. Team focus, results orientation and ethical behavior is her ethos.

Rita has many career firsts that include the first FDA approved aortic stent graft, first interventional venous thrombus protection device, first US industry data registries with the Society of Vascular Surgery and the American Venous Forum and the first to obtain FDA approval to change a PMA clinical study strategy from RCT to TPG. For these Class III device projects Rita developed study protocols that met FDA PMA requirements, recruited qualified study investigators/sites, managed the studies in compliance with Good Clinical Practices (GCP) and prepared final statistical analyses and PMA study reports. She has established and completed publication strategies resulting in physician authored manuscript acceptance in TierI and II peer reviewed journals. Rita creates and delivers training curricula to physicians and company sales, marketing, engineering and customer service employees.

Rita has a BS in Nursing from the University of Maryland. RN licensure incudes Maryland and California, now inactive.